1. Cheng W, Li HL, Xi SY, Zhang XF, Zhu Y, Le Xing, Mo YX, Li MM, Kong FE, Zhu WJ, Chen XG,
Cui HQ, Cao ZM, Gong YF, Tang YQ, Zhang Y, Guan XY, Ma NF, Liu M. Growth differentiation factor
1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma.
Nat Commun. 2021; 12:7142.
2. Kong FE, Li GM, Tang YQ, Xi SY, Loong JHC, Li MM, Li HL, Cheng W, Zhu WJ, Mo JQ, Gong
YF, Tang H, Zhao Y, Zhang Y, Ma S, Guan XY, Ma NF, Xie MB, Liu M. Targeting tumor lineage plasticity
in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate. Sci Transl Med. 2021; 13:
eabb6282.
3. Yang XD, Kong FE, Qi L, Lin JX, Yan Q, Loong JHC, Xi SY, Zhao Y, Zhang Y, Yuan YF, Ma NF,
Ma S, Guan XY, Liu M. PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the
pluripotent transcriptome in hepatocellular carcinoma. Mol Cancer. 2021; 20:20.
4. Liu M, Yan Q, Sun Y, Nam Y, Hu L, Loong JHC, Ouyang Q, Zhang Y, Li HL, Kong FE, Li L, Li Y,
Li MM, Cheng W, Jiang LX, Fang S, Yang XD, Mo JQ, Gong YF, Tang YQ, Li Y, Yuan YF, Ma NF, Lin
G, Ma S, Wang JG, Guan XY. A hepatocyte differentiation model reveals two subtypes of liver cancer with
different oncofetal properties and therapeutic targets. Proc Natl Acad Sci U S A. 2020; 117:6103-6113.
5. Fang S, Liu M, Li L, Zhang FF, Li Y, Yan Q, Cui YZ, Zhu YH, Yuan YF, Guan XY. Lymphoid
enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by
directly activating the NOTCH pathway. Oncogene. 2019; 38:4061-4074.
6. Liu M, Chen L, Ma NF, Chow RK, Li Y, Song Y, Chan TH, Fang S, Yang X, Xi S, Jiang L, Li Y,
Zeng TT, Li Y, Yuan YF, Guan XY. CHD1L Promotes Lineage Reversion of Hepatocellular Carcinoma
through Opening Chromatin for Key Developmental Transcription Factors. Hepatology. 2016;
63:1544-1559.
7. Liu M, Jiang L, Guan XY. The genetic and epigenetic alterations in human hepatocellular carcinoma:
a recent update. Protein Cell. 2014; 5:673-691.
8. Liu M, Li Y, Chen L, Chan TH, Song Y, Fu L, Zeng TT, Dai YD, Zhu YH, Li Y, Chen J, Yuan YF,
Guan XY. Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with
progression of hepatocellular carcinoma. Gastroenterology. 2014; 146:1084-1096.
9. Liu M, Chen LL, Chan TH. Wang J, Li Y, Li Y, Zeng TT, Yuan YF, Guan XY. Serum and
glucocorticoid kinase 3 at 8q13.1 promote cell proliferation and survival in hepatocellular
carcinoma. Hepatology. 2012; 55:1754-1765.
代表性成果: